Skip to main content

Advertisement

Table 1 Baseline characteristics of study patients

From: Multicenter study on hemorrhagic risk of heparin bridging therapy for periendoscopic thromboprophylaxis

  Upper GI treatment Lower GI treatment Total
HBT patients (number) 171 74 245
Mean age (mean ± S.D.) 74.1 ± 8.6 71.7 ± 8.0 73.4 ± 8.5
Sex (M: F) 142:29 57:17 199:46
Therapy before HBT    
anticoagulants 91 43 134
antiplatelets 80 31 111
Antithrobmotic    
Single 80 32 112
Multiple 91 42 133
Condition requiring antithrobmotic    
Atrial fibrillation 46 22 68
Ischemic heart disease 53 33 86
Deep vein thrombosis 7 1 8
Valve replacement 9 8 17
Arteriosclerosis obliterans 5 4 9
Cerebrovascular disease 46 18 64
Type of heparin used    
Unfractionated heparin 171 68 239
LMWH 0 6 6
  1. HBT: heparin bridge therapy, GI: gastrointestinal, LMWH: low molecular- weight heparin. A patient could be counted under more than one condition